Q3 2016 13F Holders as of 9/30/2016
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
14.4M
-
Number of holders
-
158
-
Total 13F shares, excl. options
-
10.9M
-
Shares change
-
-414K
-
Total reported value, excl. options
-
$521M
-
Value change
-
-$20.6M
-
Put/Call ratio
-
1.69
-
Number of buys
-
76
-
Number of sells
-
-72
-
Price
-
$47.85
Significant Holders of Anika Therapeutics, Inc. - Common Stock, par value $0.01 per share (ANIK) as of Q3 2016
176 filings reported holding ANIK - Anika Therapeutics, Inc. - Common Stock, par value $0.01 per share as of Q3 2016.
Anika Therapeutics, Inc. - Common Stock, par value $0.01 per share (ANIK) has 158 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 10.9M shares
of 14.4M outstanding shares and own 75.44% of the company stock.
Largest 10 shareholders include WELLINGTON MANAGEMENT GROUP LLP (1.13M shares), BlackRock Fund Advisors (1.04M shares), VANGUARD GROUP INC (832K shares), DIMENSIONAL FUND ADVISORS LP (730K shares), THOMPSON SIEGEL & WALMSLEY LLC (594K shares), BTIM Corp. (401K shares), BlackRock Institutional Trust Company, N.A. (366K shares), STATE STREET CORP (307K shares), KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC (289K shares), and AMI ASSET MANAGEMENT CORP (286K shares).
This table shows the top 158 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.